A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2002
12/31/2002	US6500837 Treating parkinson's disease
12/31/2002	US6500836 Fungicidal active compound combinations
12/31/2002	US6500835 Preventive or therapeutic drugs for fibrosis containing chymase inhibitors as the active ingredient
12/31/2002	US6500834 Mixtures of caffeine, ethanol, enzyme/hydrolases and kinases, tissue and urokinase plasminogen activators, aspirin and dipyridamole used as neuroprotectants during traumas
12/31/2002	US6500833 Administering risperidones for the prophylaxis of psychoses, drug aduse or dependence and as emetic agents having side effect reduction
12/31/2002	US6500832 Administering enzyme inhibitors as viricides for prophylaxis of viral diseases such as aquired immune deficiency syndrome
12/31/2002	US6500831 Non-peptide bradykinin receptor antagonists for use in controlling intraocular pressure and treating glaucoma
12/31/2002	US6500830 Conversion of modification D to modification A of doxazosin mesylate
12/31/2002	US6500829 Mixtures of stereoisomers used as anticarcinogenic agents or for the treatment of vitamin deficiency
12/31/2002	US6500828 Triazolo-pyridazine derivatives as ligands for gaba receptors
12/31/2002	US6500827 Drug combinations
12/31/2002	US6500826 Use of panaverium bromide for preventing cell proliferation and diseases caused thereby in the liver and digestive tract
12/31/2002	US6500825 Substituted 2-aminoacetamides and the use thereof
12/31/2002	US6500823 Energy deficiency of the cell caused by parp inhibition, in diabetes complications, in oxygen deficient status of the heart and brain, in neurodegenerative diseases, in the treatment of autoimmune and/or viral diseases
12/31/2002	US6500822 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
12/31/2002	US6500821 Treat various forms of epilepsies and of states of anxiety and tension.
12/31/2002	US6500820 Pharmaceutical composition for neurotrophic action
12/31/2002	US6500819 Has an excellent anxiolytic effect
12/31/2002	US6500818 Naphthalenecarboxamides as tachykinin receptor antagonists
12/31/2002	US6500817 Thiazolyl urea derivatives and their utilization as antiviral agents
12/31/2002	US6500814 Hormonal contraceptive
12/31/2002	US6500813 Preventing deterioration of the optical transparency, occurrence of high intraocular pressure diseases or defective sight, observed after an ophthalmic operation, due to hyperplasia of the anterior ocular cells in the tissues
12/31/2002	US6500812 Gastrointestinal disorders; antiinflammatory agents
12/31/2002	US6500811 Prophylaxis and therapy of disorders in the course of which an increased activity of matrix-degrading enzymes is involved; these include degenerative joint disorders such as osteoarthroses and disorders of connective tissue
12/31/2002	US6500810 Especially a mixture of phosphatidic acid, phosphatidyl inositol, lysophosphatidic acid, lysophosphatidyl choline and lysophosphatidyl inositol.
12/31/2002	US6500809 Neural tissue edema is treated by circulating a hyperoncotic artificial cerebrospinal fluid in the cerebrospinal fluid pathway in the vicinity of edematous tissue to cause the edematous tissue to be dehydrated due to an oncotic gradient
12/31/2002	US6500808 Anti-viral composition
12/31/2002	US6500805 Fructan containing composition for the prevention and treatment of colon cancer and method for the prevention and treatment of same
12/31/2002	US6500804 Administering a dipeptidyl aminopeptidase effector which is selected from the group consisting of n-(n-substituted glycyl)2-cyanopyrrolidones, n-aminoacyl thiazolidines, n-aminoacyl pyrrolidines
12/31/2002	US6500777 Bioresorbable oxidized cellulose composite material for prevention of postsurgical adhesions
12/31/2002	US6500672 A competitive assay for binding activity to recombinant hepatocyte nuclear factor-4 receptors, a chimeric receptor comprising the ligand binding domain of a hnf-4 receptor and dna binding domain of another receptor
12/31/2002	US6500613 Isolated pneumococcal surface protein c, pspc, of strepto-coccus pneumoniae having alpha-helical, proline rich and repeat regions
12/31/2002	US6500610 Administering compounds that exhibit phosphodiesterase and cyclooxygenase inhibitory activity and apoptosis induction but prefereably not prostaglandin inhibitory activity on cultured tumor cells
12/31/2002	US6500472 For enriching foods or beverages, anemia treatment
12/31/2002	US6500466 Chlorhexidine formulations, new chlorhexidine salts, solutions containing these and their use
12/31/2002	US6500461 Core comprising poorly hydrophilic compound, conjugate of biocompatible hydrophilic domain and biocompatible hydrophobic domain, conjugate surrounding core
12/31/2002	US6500460 Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention, and an applicator for the delivery of topical formulations into mucosal cavities
12/31/2002	US6500456 Compressed nitroglycerin tablet and its method of manufacture
12/31/2002	US6500455 Coating crystalline, racemic tolperisone in coating column which is operated with air flow with mixture of methanol and solution of synthetic, semisynthetic or natural hydrogels in chloroform to produce delayed release preparation
12/31/2002	US6500454 Dosage form of timed, sustained release beads comprising core particle of propranolol coated with ethyl cellulose membrane to sustain drug release and outer membrane comprising mixture of ethyl cellulose and enteric polymer providing lag time
12/31/2002	US6500452 Mixture of aminobenzoic acid, hydroxybenzoic acid, cysteine, methionine, selenium, lithium bromide and plant extracts
12/31/2002	US6500451 Activation
12/31/2002	US6500450 Composition for treating migraine headaches
12/31/2002	US6500448 Composition comprising biocompatible polymer matrix having particles of metal cation-complexed human growth hormone dispersed therein, and aqueous injection vehicle comprising low viscosity sodium carboxymethyl cellulose
12/31/2002	US6500432 Method to enhance an immune response of nucleic acid vaccination
12/31/2002	US6500418 Stimulating neutrophil function to treat inflammatory bowel disease
12/31/2002	US6500411 A particulate material and a natural polymer free of carboxymethyl cellulose or xanthan gum for addtion to a formulation including a hydrophilic liquid selected from water, a hydrophilic organic liquid, and mixture; sunscreen
12/31/2002	US6500409 Oral antigingivitis composition comprising an orally acceptable vehicle of a combination of a noncationic halogenated hydroxydiphenyl ether and an extract of magnolia cortex, the bark of magnolia officinalis such as magnolol
12/31/2002	US6500178 Spine distraction implant and method
12/31/2002	CA2414971A1 Drug for curing or preventing mood disorder or anxiety disorder
12/31/2002	CA2227814C Substituted benzylaminopiperidine compounds
12/31/2002	CA2097732C Composition comprising r-alpha-lipoic acid and vitamin e for treating diabetes mellitus
12/31/2002	CA2094121C 5-iodo-6-amino-1,2-benzopyrones and their analogs useful as cytostatic and antiviral agents
12/31/2002	CA2064112C .alpha.-dihydroergocryptine pharmaceutical preparations with neuroprotective activity
12/31/2002	CA2029524C Transdermal administration of 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole
12/29/2002	CA2392383A1 A complex comprising ocif and polysaccharide
12/28/2002	CA2391205A1 Benzoic acid substituted benzopyrans for the treatment of atherosclerosis
12/27/2002	WO2002103971A2 Multicarrier receiver
12/27/2002	WO2002103055A1 METHOD OF DETERMINING A CHEMOTHERAPEUTIC REGIMEN BASED ON GLUTATHIONE-S-TRANSFERASE Pi EXPRESSION
12/27/2002	WO2002103042A2 Method and nucleic acids for the differentiation of prostate tumors
12/27/2002	WO2002103015A2 Abca10 transporter
12/27/2002	WO2002103014A2 Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells
12/27/2002	WO2002103000A2 Methods for modulating gap junctions
12/27/2002	WO2002102988A2 Method for neural stem cell differentiation using 5ht-1a agonists
12/27/2002	WO2002102981A2 SIR2α-BASED THERAPEUTIC AND PROPHYLACTIC METHODS
12/27/2002	WO2002102978A2 Human growth hormone antagonists
12/27/2002	WO2002102976A2 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571
12/27/2002	WO2002102822A1 Adenosine derivative in polymorph ii form
12/27/2002	WO2002102821A1 Adenosine derivative in polymorph i form
12/27/2002	WO2002102817A1 Anti-tumour anthracycline glycoside 14-sulfonic acid derivatives
12/27/2002	WO2002102814A1 Apoptosis inducer
12/27/2002	WO2002102813A1 Aryldifluoromethylphosphonic acids for treatment of diabetes
12/27/2002	WO2002102808A2 (PYRIDO/THIENO)-[f]-OXAZEPIN-5-ONE DERIVATIVES AS POSITIVE MODULATORS OF THE AMPA RECEPTOR
12/27/2002	WO2002102805A1 NEW USE Of CYCLOLIGNANS AND NEW CYCLOLIGNANS
12/27/2002	WO2002102804A1 New use of specific cyclolignans
12/27/2002	WO2002102802A1 Novel pyrazolopyrimidinethione derivatives. preparation methods thereof and their use as therapeutics for erectile dysfunction
12/27/2002	WO2002102801A1 Tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
12/27/2002	WO2002102800A1 5-(2-aminopyrimidin-4-yl) benzisoxazoles as protein kinase inhibitors
12/27/2002	WO2002102799A2 Pyrrolidine oxadiazole- and thiadiazole oxime derivatives being oxytocin receptor antagonists
12/27/2002	WO2002102794A2 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/27/2002	WO2002102793A2 Quinazolinediones as antibacterial agents
12/27/2002	WO2002102792A1 Novel heterocyclic antibacterial compounds
12/27/2002	WO2002102791A1 Pyrrolidine bicyclic compounds
12/27/2002	WO2002102790A1 N-formyl hydroxylamine compounds as inhibitors of pdf
12/27/2002	WO2002102788A1 Crystalline salts of benzoylbenzofuran-derivatives
12/27/2002	WO2002102787A2 Novel sulfonic acid derivatives
12/27/2002	WO2002102785A1 Novel bicyclic isoxazolinones as antibacterial agents
12/27/2002	WO2002102783A1 Tyrosine kinase inhibitors
12/27/2002	WO2002102782A2 QUINAZOLINE DERIVATIVES which PROMOTE THE RELEASE OF PARATHYROID_HORMONE
12/27/2002	WO2002102780A1 Tetrahydroquinoline derivative compound and drug containing the compound as active ingredient
12/27/2002	WO2002102778A1 Phenylpyridine carbonyl piperazine derivative
12/27/2002	WO2002102777A2 NOVEL CRYSTALLINE FORMS OF 4-[4-[4-(HYDROXYDIPHENYLMETHYL)-1-PIPERINDINYL]-1-HYDROXYBUTYL]-α, α-DIMETHYLBENZENE ACETIC ACID AND ITS HYDROCHLORIDE
12/27/2002	WO2002102776A1 Process for the production of the piperidine derivative fexofenadine
12/27/2002	WO2002102774A1 4-piperazinylindole derivatives with 5-ht6 receptor affinity
12/27/2002	WO2002102771A1 Tryptase inhibitors
12/27/2002	WO2002102770A1 Novel aliphatic compound, method of synthesis, and method of utilization
12/27/2002	WO2002102766A2 Combretastatin a-3 prodrug
12/27/2002	WO2002102757A1 Glycerol-peg-derivatives as inhibitors of cyclooxygenase-2 and phospholipase-a2
12/27/2002	WO2002102743A2 DEUTERATED N-SUBSTITUTED AND α-SUBSTITUTED DIPHENYLALKOXY ACETIC ACID AMINO ALKYL ESTERS AND MEDICAMENTS CONTAINING THESE COMPOUNDS
12/27/2002	WO2002102414A1 Medicinal compositions

1 ... 5607 5608 5609 5610 5611 5612 5613 5614 5615 5616 5617 5618 5619 5620 5621 5622 5623 5624 5625 5626 5627 ... 7860